Statements of Cash Flows - USD ($)
$ in Thousands |
12 Months Ended |
Dec. 31, 2015 |
Dec. 31, 2014 |
Dec. 31, 2013 |
| Cash flows from operating activities: |
|
|
|
| Net loss |
$ (41,230)
|
$ (5,811)
|
$ (19,125)
|
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: |
|
|
|
| Goodwill impairment |
14,278
|
|
|
| Depreciation and amortization |
318
|
275
|
280
|
| Provision for doubtful accounts |
233
|
39
|
107
|
| Provision for warranties |
385
|
447
|
392
|
| Provision for inventory |
469
|
|
|
| Change in fair value of warrants |
(360)
|
220
|
46
|
| Non-cash interest expense |
1,386
|
490
|
179
|
| Stock-based compensation expense |
2,382
|
594
|
342
|
| Changes in assets and liabilities: |
|
|
|
| Accounts receivable |
715
|
875
|
(2,868)
|
| Prepaid expenses, other current assets and other assets |
147
|
(864)
|
195
|
| Inventories |
(898)
|
1,359
|
(10,852)
|
| Accounts payable |
1,546
|
(2,266)
|
1,904
|
| Accrued and other liabilities |
1,571
|
1,385
|
(70)
|
| Customer deposits |
874
|
3,707
|
3,593
|
| Net cash (used in) provided by operating activities |
(18,184)
|
450
|
(25,877)
|
| Cash flows from investing activities: |
|
|
|
| Purchase of property and equipment |
(1,128)
|
(439)
|
(71)
|
| Contingent payment related to Silimed acquisition |
|
|
(18,000)
|
| Net cash used in investing activities |
(1,128)
|
(439)
|
(18,071)
|
| Cash flows from financing activities: |
|
|
|
| Proceeds from exercise of stock options |
119
|
38
|
10
|
| Repurchase of common stock |
|
|
(260)
|
| Proceeds from issuance of common stock, net of underwriters discount |
62,040
|
80,213
|
|
| Proceeds from issuance of common stock under employee stock purchase plan |
564
|
|
|
| Deferred equity issuance costs, IPO |
(71)
|
(3,107)
|
|
| Deferred equity issuance costs, follow-on offering |
(643)
|
|
|
| Proceeds from issuance of long-term debt |
|
10,000
|
15,000
|
| Repayment of long-term debt |
(26,625)
|
|
|
| Deferred financing costs |
|
(148)
|
(288)
|
| Net cash provided by financing activities |
35,384
|
86,996
|
14,462
|
| Net increase (decrease) in cash and cash equivalents |
16,072
|
87,007
|
(29,486)
|
| Cash and cash equivalents at: |
|
|
|
| Beginning of period |
96,729
|
9,722
|
39,208
|
| End of period |
112,801
|
96,729
|
9,722
|
| Supplemental disclosure of cash flow information: |
|
|
|
| Interest paid |
1,884
|
1,577
|
$ 641
|
| Supplemental disclosure of non-cash investing and financing activities: |
|
|
|
| Accrued equity issuance costs |
|
71
|
|
| Property and equipment in accounts payable |
$ 22
|
$ 44
|
|